Du hast nach gesucht - Tolerogenics S.a.r.l.

Company
Technology
Pipeline
Patents
Contact

New Search

If you are not happy with the results below please do another search

Tolerogenics S.à.r.l.

Tolerogenics is developing novel immunotherapies for allergy & autoimmune diseases based on induction of tolerance. The company is a private-public-partnership with the Luxembourg Institute of Health (LIH).

Investment opportunity

Tolerogenics S.à.r.l. is offering several investment opportunities in the field of novel allergen- or autoantigen-specific immunotherapies.

Contact us for more information.

Contact

29, Rue Henri Koch
L-4354 Esch-sur-Alzette
Luxembourg

contact@tolerogenics.lu

© Copyright 2016 - Tolerogenics S.à.r.l. - Imprint & Disclaimer

We use cookies to ensure that we give you the best experienve on our website. If you continue to use this site we will assume that you accept this.I accept cookies